Related content

Mass spectrometry-based clinical proteomics

By Pusch Wolfgang   Flocco Mark T   Leung Sau-Mei   Thiele Herbert   Kostrzewa Markus  

Pharmacogenomics, Vol. 4, Iss. 4, 2003-07 ,pp. : 463-476

Future Medicine

Access to resources Recommend Favorite

Bioanalytical Applications of Accelerator Mass Spectrometry for Pharmaceutical Research

By  

Current Pharmaceutical Design, Vol. 6, Iss. 10, 2000-07 ,pp. : 991-1007

Bentham Science Publishers

Access to resources Recommend Favorite

Basic and clinical research leading to the use of naltrexone in the treatment of alcoholism

By O'Brien C.P.   Volpicelli J.R.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 194-195

Elsevier

Access to resources Recommend Favorite

Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 6, Iss. 2, 2007-04 ,pp. : 89-105

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropharmacology of Cannabinoid System: From Basic Science to Clinical Applications

By  

Current Neuropharmacology, Vol. 2, Iss. 1, 2004-01 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite